FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SICONOLFI GARY A 		2. Issuer Name and Ticker or Trading Symbol

CurAegis Technologies, Inc. [ CRGS ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

1999 MT. READ BLVD., BUILDING #3 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/6/2016
(Street)

ROCHESTER, NY 14615
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/6/2016     C    250000   A   (1) 863333   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series C Voting Convertible Preferred Stock     (1) 12/6/2016     C         250000    9/23/2011   9/23/2021   Common Stock   250000     (1) 0   (2) D    
Common Stock Purchase Warrant   $0.25   12/7/2016     A      24000       12/7/2016   12/7/2026   Common Stock   24000   $0.25   24000   D    
Convertible Promissory Note   $0.25   12/7/2016     A      $60000       12/7/2016   12/7/2021   Common Stock   $60000   $0.25   $60000   D    

Explanation of Responses:
( 1)  The reporting person converted 250,000 shares of Series C Voting Convertible Preferred Stock, par value $.01 per share, into an equivalent number of shares of Common Stock of the Company, par value $.01 per share, resulting in his acquisition of 250,000 shares of Common Stock of the Company.
( 2)  The reported securities are included within 250,000 Investment Units purchased by the reporting person on 09/23/2011. Each Investment Unit consists of one (1) share of the Company's Series C Voting Convertible Preferred Stock, par value $.01 per share, initially convertible into an equivalent number of shares of Common Stock of the Company, par value $.01 per share, and a warrant to purchase one-tenth (1/10) of a share of Common Stock exercisable immediately for ten years at an initial exercise price equal to the greater of (i) $.01, or (ii) 80% of the volume weighted average sales price per share of the Company's Common Stock during the ten consecutive trading days immediately preceding the notice of exercise.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SICONOLFI GARY A
1999 MT. READ BLVD., BUILDING #3
ROCHESTER, NY 14615 		X



Signatures
Kathleen A. Browne, POA for Gary A. Siconolfi 12/7/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CurAegis Technologies (CE) (USOTC:CRGS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CurAegis Technologies (CE) Charts.
CurAegis Technologies (CE) (USOTC:CRGS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CurAegis Technologies (CE) Charts.